Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
Pure Extracts is now trading under the symbol "PULL".
Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
Pure Extracts Corp. is an extraction specialist targeting the cannabis, psychedelics and functional mushrooms sectors and will trade on the CSE under the symbol "PULL".
This dosing study on LSD will be utilized as MindMed prepares for its Phase 2b clinical trial of LSD for anxiety.
With MindMed's latest financing, total cash reserves now stand at CAD$50.1 million.
Fitness wearables company, Hapbee Technologies, is going to commence trading October 30th on the TSX Venture Exchange (symbol "HAPB").
M2Bio Sciences (Wuhan General Group) has finalized an agreement with the University of Pretoria (South Africa) to conduct a psilocybin-based clinical trial.
Champignon Brands is hopeful that the B.C. Securities Commission is close to revoking its Cease Trade Order for SHRM.
Field Trip's new psychedelic molecule, FT-104, is showing similar efficacy to psychedelics like psilocybin -- but with shorter duration.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now